Trials / Completed
CompletedNCT00116896
Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors
Phase I Study of OSI-7904L in Combination With Cisplatin in Patients With Advanced Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 25 (planned)
- Sponsor
- OSI Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase I, open-label, dose escalation, study of the combination of cisplatin and OSI-7904L given on Day 1 every 21 days in patient who have advanced solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OSI-7904L | |
| DRUG | Cisplatin |
Timeline
- Start date
- 2003-06-01
- Completion
- 2004-12-01
- First posted
- 2005-07-01
- Last updated
- 2009-01-21
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00116896. Inclusion in this directory is not an endorsement.